Quantum BioPharma Ltd.

CNSX:QNTM Stock Report

Market Cap: CA$17.7m

Quantum BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:QNTM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 May 24SellCA$424,996Donal CarrollIndividual14,973.35CA$28.38

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of QNTM?
Owner TypeNumber of SharesOwnership Percentage
Institutions75,5213.92%
Individual Insiders324,45916.8%
General Public1,526,93279.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 213.7%.

Top Shareholders

Top 16 shareholders own 20.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.08%
Zeeshan Saeed
117,207CA$1.1m0%no data
5.19%
Anthony Durkacz
100,007CA$920.1k0%no data
4.29%
Donal Carroll
82,720CA$761.0k0%no data
3.58%
AdvisorShares Investments, LLC
69,078CA$635.5k163%0.06%
1.14%
Lakshmi Kotra
21,881CA$201.3k0%no data
0.3%
First Republic Capital Corp, Asset Management Arm
5,749CA$52.9k0%100.0%
0.13%
Nathan Coyle
2,500CA$23.0k0%no data
0.02%
RBC Dominion Securities Inc., Asset Management Arm
379CA$3.5k268%no data
0.0075%
Adnan Bashir
144CA$1.3k0%no data
0.0069%
Group One Trading LP, Asset Management Arm
133CA$1.2k-22.7%no data
0.0052%
SBI Holdings Inc., Asset Management Arm
100CA$920.10%no data
0.0018%
National Bank Investments Inc.
34CA$312.0-29.2%no data
0.0014%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
28CA$257.1100%no data
0.00078%
Osaic Wealth, Inc. , Asset Management Arm
15CA$138.30%no data
0.00016%
Avior Wealth Management, LLC
3CA$28.40%no data
0.0001%
Toronto-Dominion Bank, Banking Investments
2CA$17.7-33.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/19 06:14
End of Day Share Price 2025/03/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum BioPharma Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets